IQVIA Holdings Inc logo

IQVIA Holdings Inc

NYSE:IQV (USA)  
$ 234.88 +0.9 (+0.38%) 10:08 PM EST
32.22
P/B:
6.97
Market Cap:
$ 42.75B
Enterprise V:
$ 54.99B
Volume:
636.00K
Avg Vol (2M):
843.22K
Also Trade In:
Volume:
636.00K
Avg Vol (2M):
843.22K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for IQV ( IQVIA Holdings Inc ) from 2013 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. IQVIA stock (IQV) PE ratio as of Apr 27 2024 is 32.22. More Details

IQVIA Holdings Inc (IQV) PE Ratio (TTM) Chart

To

IQVIA Holdings Inc (IQV) PE Ratio (TTM) Historical Data

Total 1217
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
IQVIA PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-27 32.2 2024-02-23 33.9
2024-04-26 32.2 2024-02-22 33.9
2024-04-25 32.1 2024-02-21 32.5
2024-04-24 33.0 2024-02-20 32.2
2024-04-23 32.7 2024-02-16 32.7
2024-04-22 31.7 2024-02-15 33.1
2024-04-19 31.3 2024-02-14 33.4
2024-04-18 31.2 2024-02-13 29.5
2024-04-17 31.2 2024-02-12 29.9
2024-04-16 31.4 2024-02-09 29.9
2024-04-15 31.7 2024-02-08 29.8
2024-04-12 32.1 2024-02-07 29.4
2024-04-11 32.6 2024-02-06 29.6
2024-04-10 32.8 2024-02-05 28.9
2024-04-09 33.6 2024-02-02 28.9
2024-04-08 33.1 2024-02-01 29.0
2024-04-05 33.1 2024-01-31 28.6
2024-04-04 32.7 2024-01-30 29.8
2024-04-03 33.3 2024-01-29 29.9
2024-04-02 33.7 2024-01-26 29.6
2024-04-01 34.1 2024-01-25 29.6
2024-03-28 34.7 2024-01-24 29.2
2024-03-27 34.6 2024-01-23 29.3
2024-03-26 34.0 2024-01-22 29.9
2024-03-25 34.1 2024-01-19 29.6
2024-03-22 34.6 2024-01-18 29.2
2024-03-21 34.9 2024-01-17 28.9
2024-03-20 34.7 2024-01-16 29.2
2024-03-19 34.9 2024-01-12 29.3
2024-03-18 34.8 2024-01-11 29.4
2024-03-15 34.7 2024-01-10 29.8
2024-03-14 34.9 2024-01-09 30.4
2024-03-13 35.1 2024-01-08 30.7
2024-03-12 35.5 2024-01-05 30.3
2024-03-11 35.5 2024-01-04 30.2
2024-03-08 35.3 2024-01-03 30.2
2024-03-07 35.5 2024-01-02 31.6
2024-03-06 34.7 2023-12-29 31.7
2024-03-05 34.3 2023-12-28 31.9
2024-03-04 34.5 2023-12-27 39.0
2024-03-01 34.6 2023-12-26 38.8
2024-02-29 33.9 2023-12-22 38.5
2024-02-28 34.3 2023-12-21 38.5
2024-02-27 34.1 2023-12-20 37.8
2024-02-26 34.0 2023-12-19 38.5

IQVIA Holdings Inc (IQV) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.